Nexus Pharmaceuticals, a US-based healthcare company, has introduced Tranexamic Acid.

This milestone is another step for Nexus in its mission to provide life-saving medication to those who need it most.

“We are very excited to be adding Tranexamic Acid to our product portfolio. Antifibrinolytic Agents, such as Tranexamic Acid, are crucial to have available in operating rooms and we are proud to contribute to the supply,” said Vince LoPiccolo, Vice President of Sales at Nexus.

Tranexamic Acid is now available in cartons of 10 bags.

Nexus Pharmaceuticals, LLC., a US-based healthcare company, specializes in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice.

Nexus ensures that its high-quality drug products fulfill a critical unmet medical need and deliver dependable life-saving treatment options when and where they’re needed most.